Commit Biologics

📍 Aarhus, Denmark🗓 Founded 2021👥 27 employees💰 Last funded Jan 2023
Biotechnology🌐 commitbio.com
Website LinkedIn
Commit Biologics (Commit) is a pioneer in activating the complement system to kill specific target cells, with applications in cancers and autoimmune diseases. Spun out of Aarhus University, and building on more than three decades of research, Commit’s Bispecific Complement Engaging (BiCE™) platform can supercharge a conventional monoclonal antibody to activate the complement system more effectively. This is achieved by combining single domain antibodies that engage C1q, the starting point for the complement activation cascade, with an antibody that binds to a cellular target. The modular approach of the BiCE™ technology can be used to develop therapeutics across multiple tumor-associated antigens and immune cell targets. Complement is a largely untapped aspect of the body’s natural immune system that leverages both the direct cytolytic activity of complement along with its ability to bridge recruitment and activation of both innate and adaptive immune cells – a new approach to killing cells which can be used in combination or on a standalone basis. Commit is backed by major investors including Bioqube Ventures and Novo Holdings, as well as initial funding from the Bio Innovation Institute from Denmark.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Belgium
1
Denmark
1
Frequently asked questions
Who invested in Commit Biologics?
Commit Biologics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Commit Biologics last raise funding?
The most recent investment in Commit Biologics recorded on gritt.io was in January 2023.
When was Commit Biologics founded?
Commit Biologics was founded in 2021.
What industry is Commit Biologics in?
Commit Biologics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Commit Biologics based?
Commit Biologics is headquartered in Aarhus, Denmark.